IL21/CD40L stimulation significantly increased the expression of Granzyme B (GrB) in B cells from healthy subjects, whereas it remained weakly expressed in CLL patients regardless of stimulation (Fig. S2E). This evidence concerns the gene IL21 and B-cell chronic lymphocytic leukemia.